Table 1.
Total (N=59) | |
---|---|
Age^ | |
Median (min, max) | 60.7 (37.4, 90.5) |
N (%) | |
<65 | 35 (59.3) |
≥65 | 24 (40.7) |
Sex | |
Female | 29 (49.2) |
Male | 30 (50.8) |
Smoking* | |
No | 29 (50.0) |
Yes | 29 (50.0) |
Histology | |
Adenocarcinoma | 56 (94.9) |
Squamous cell | 3 (5.1) |
PS^ | |
0 | 36 (61.0) |
1 | 21 (35.6) |
2 | 1 (1.7) |
3 | 1 (1.7) |
Brain metastases^ | |
No | 51 (86.4) |
Yes | 8 (13.6) |
Notes: *Data not available for all subjects. Missing values: Smoking= 1. ^ At afatinib administration.
Abbreviation: PS, Performance status.